Tandem and Eli Lilly carried out trials to demonstrate the advantages of using Lyumjev in combination with Control-IQ ...

CGMs are especially useful for diabetics with an insulin-dependent condition who self-administer their medication. Dexcom has become a leader in the field of diabetic monitoring technology.

Modular Medical shares rose after hours as the company received Food and Drug Administration clearance for its MODD1 insulin pump. The stock was up 27%, to $2.49, surpassing the prior 52-week high ...

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at an ...

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at ...

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will spotlight the significant benefits of its innovative CGM technology at an ...

With this, Tandem Diabetes became the only company that offers two insulin pump options that connect with both Dexcom G6 and Dexcom G7, providing more choices in terms of diabetes management.

300-unit insulin reservoir is more suitable for people with T2D who are interested in moving from multiple daily injections (MDI) to pump therapy, based on an average daily dose of 95.9 units of ...

They can also be paired with pumps to automate the insulin delivery process. Many studies have concluded that CGMs help diabetes patients achieve better health outcomes. DexCom has been successful ...